Medicus Pharma (NASDAQ:MDCX) earlier this week outlined progress in the development of its investigational therapy Teverelix, ...
WhiteSands Alcohol & Drug Rehab has published a new educational resource exploring how long phencyclidine, commonly known as ...
WhiteSands Alcohol & Drug Rehab has published a new resource on its website examining a patient-reported recovery experience ...
A new experimental vaccine takes aim at one of tuberculosis’s most stubborn defenses: the ability of bacteria to persist ...
B-cell acute lymphoblastic leukemia is the most common form of childhood cancer. In this type of cancer, which affects blood ...
B-cell acute lymphoblastic leukaemia is the most common form of childhood cancer. In this type of cancer, which affects blood ...
SkinJect™ , a novel localized immuno-oncology precision product focused on non-melanoma skin diseases, especially basal cell carcinoma (BCC) and Gorlin Syndrome , a rare autosomal dominant disease ...
A new review led by Yeshin Woo and Kibum Jung assesses this transformation, examining how AI technologies are being ...
Emerging research suggests milk fever may be less about calcium deficiency and more about how inflammation and metabolism ...
SurvivorNet on MSN
When multiple myeloma returns: How doctors are sequencing Tec‑Dara and CAR T-cell therapy
There are now two very powerful but very different approaches that can be considered as early as first relapse for patients ...
Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company"), a biotech/life sciences company focused on advancing the clinical development programs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results